Analyst Conference Summaries

Biotechnology Investor Aids

Avidity Biosciences

conference date: May 12, 2021 (press relase only)

Avidity Biosciences Has A Promising RNA Therapy Platform [January 12, 2020 at Seeking Alpha]

Q4 2020
Q1 2021
March 16, 2021 May 12, 2021    

Avidity Biosciences (RNA) is a preclinical-stage biotechnology company specializing in a novel RNA therapy platform for diseases caused by genetic mutations.

Avidity Biosciences web site



More Analyst Conference Pages:


Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers